Canada: Recall of Cannabis for Medical Purposes – Aphria (English Only)
 
Health Canada announces that Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary Type III recall of two lots of dried marijuana that were produced between 19 Jan 2018 and 22 Jan 2018. The affected lot numbers are 1256-6712 and 1256-6714. Aphria initiated a voluntary Type III recall for two lots of dried marijuana sold in 10g bottles due to a labelling error. The labels omitted to indicate the percent sign (%) next to the numerical values for cannabinoid content. 

A Type III recall refers to a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences. 

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. 

Please refer to the following website in Health Canada for details: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../65848r-eng.php 

In Hong Kong, the above product is not a registered pharmaceutical product. 

Ends/Wednesday, Jan 31, 2018 
Issued at HKT 15:00 

轉載自衛生署藥物辦公室網頁http://www.drugoffice.gov.hk/